Lithium augmentation in venlafaxine-refractory depression [LE4]

Journal of Clinical Psychopharmacology

Volumn 21, Issue 2, 2001, Pages 242-243

  Zullino, Daniele ^a   Preisig, Martin ^a   Baumann, Pierre ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VENLAFAXINE;

ADJUVANT THERAPY; ADULT; CASE REPORT; DEPRESSION; DRUG POTENTIATION; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; PSYCHOTHERAPY;

ANTIMANIC AGENTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CHLORIDE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 0035100122     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200104000-00021     Document Type: Letter

References (8)

1. Practical guidelines for combination drug therapy of treatment-resistant depression
2. A rational approach to the non-responding depressed patient
3. Lithium augmentation of antidepressants in treatment-refractory depression
4. Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders
5. Treatment of depression resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: Review of the literature
6. A case of serotonin syndrome caused by venlafaxine and lithium
7. Pharmacologic profile and efficacy of venlafaxine
8. Antidepressant augmentation: Conclusions and recommendations